Extracellular vesicles as a next-generation drug delivery platform

Extracellular-vesicle-based cell-to-cell communication is conserved across all kingdoms of life. There is compelling evidence that extracellular vesicles are involved in major (patho)physiological processes, including cellular homoeostasis, infection propagation, cancer development and cardiovascula...

Full description

Bibliographic Details
Main Authors: Herrmann, IK, Wood, MJA, Fuhrmann, G
Format: Journal article
Language:English
Published: Springer Nature 2021
_version_ 1797075896794873856
author Herrmann, IK
Wood, MJA
Fuhrmann, G
author_facet Herrmann, IK
Wood, MJA
Fuhrmann, G
author_sort Herrmann, IK
collection OXFORD
description Extracellular-vesicle-based cell-to-cell communication is conserved across all kingdoms of life. There is compelling evidence that extracellular vesicles are involved in major (patho)physiological processes, including cellular homoeostasis, infection propagation, cancer development and cardiovascular diseases. Various studies suggest that extracellular vesicles have several advantages over conventional synthetic carriers, opening new frontiers for modern drug delivery. Despite extensive research, clinical translation of extracellular-vesicle-based therapies remains challenging. Here, we discuss the uniqueness of extracellular vesicles along with critical design and development steps required to utilize their full potential as drug carriers, including loading methods, in-depth characterization and large-scale manufacturing. We compare the prospects of extracellular vesicles with those of the well established liposomes and provide guidelines to direct the process of developing vesicle-based drug delivery systems.
first_indexed 2024-03-06T23:56:44Z
format Journal article
id oxford-uuid:74776726-e51e-4ba9-a0fa-facf3dac5ae0
institution University of Oxford
language English
last_indexed 2024-03-06T23:56:44Z
publishDate 2021
publisher Springer Nature
record_format dspace
spelling oxford-uuid:74776726-e51e-4ba9-a0fa-facf3dac5ae02022-03-26T20:03:10ZExtracellular vesicles as a next-generation drug delivery platformJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:74776726-e51e-4ba9-a0fa-facf3dac5ae0EnglishSymplectic ElementsSpringer Nature2021Herrmann, IKWood, MJAFuhrmann, GExtracellular-vesicle-based cell-to-cell communication is conserved across all kingdoms of life. There is compelling evidence that extracellular vesicles are involved in major (patho)physiological processes, including cellular homoeostasis, infection propagation, cancer development and cardiovascular diseases. Various studies suggest that extracellular vesicles have several advantages over conventional synthetic carriers, opening new frontiers for modern drug delivery. Despite extensive research, clinical translation of extracellular-vesicle-based therapies remains challenging. Here, we discuss the uniqueness of extracellular vesicles along with critical design and development steps required to utilize their full potential as drug carriers, including loading methods, in-depth characterization and large-scale manufacturing. We compare the prospects of extracellular vesicles with those of the well established liposomes and provide guidelines to direct the process of developing vesicle-based drug delivery systems.
spellingShingle Herrmann, IK
Wood, MJA
Fuhrmann, G
Extracellular vesicles as a next-generation drug delivery platform
title Extracellular vesicles as a next-generation drug delivery platform
title_full Extracellular vesicles as a next-generation drug delivery platform
title_fullStr Extracellular vesicles as a next-generation drug delivery platform
title_full_unstemmed Extracellular vesicles as a next-generation drug delivery platform
title_short Extracellular vesicles as a next-generation drug delivery platform
title_sort extracellular vesicles as a next generation drug delivery platform
work_keys_str_mv AT herrmannik extracellularvesiclesasanextgenerationdrugdeliveryplatform
AT woodmja extracellularvesiclesasanextgenerationdrugdeliveryplatform
AT fuhrmanng extracellularvesiclesasanextgenerationdrugdeliveryplatform